Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Verbesserung der Hämorheologie durch Ginkgo-biloba-Extrakt. Verminderung eines kardiovaskulären Risikofaktors.

Improvement of hemorheology with ginkgo biloba extract. Decreasing a cardiovascular risk factor
: Witte, S.; Anadere, I.; Walitza, E.

Fortschritte der Medizin 110 (1992), No.13, pp.73-76
ISSN: 0015-8178
Journal Article
Fraunhofer IGB ()
blood; blood viscosity; cardiovascular disease; drug effect; fibrinogen; metabolism; middle age; plant extract; prospective study; rheology; risk factor; therapeutic use; therapy

STUDY DESIGN: Open prospective study. Patients: 20 outpatients with a long history of elevated fibrinogen levels and plasma viscosity, and a variety of underlying diseases. INTERVENTION: Treatment with the special ginkgo biloba extract (EGb 761), 240 mg tablets a day for a period of 12 weeks. RESULTS: The clinical diagnoses included coronary heart disease, hypertension, hypercholesterolemia and diabetes mellitus. A significant improvement in the fibrinogen levels and hemorrheological properties was seen. The medication can thus positively influence these cardiovascular risk factors over the long term.